Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Resonance Health Ltd ( (AU:RHT) ) has shared an announcement.
Resonance Health Ltd has applied to the ASX for quotation of 2,327,586 new ordinary fully paid shares issued on 27 February 2026. The new shares were issued under an employee incentive scheme and will be quoted on the market, indicating continued use of equity-based compensation and a modest expansion of the company’s share capital base.
The move underscores the company’s reliance on share-based incentives to attract and retain staff, which may slightly dilute existing holders but aligns employee interests with shareholders. The additional quoted securities could enhance trading liquidity in RHT shares and signal ongoing operational activity and investment in human capital.
The most recent analyst rating on (AU:RHT) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on Resonance Health Ltd stock, see the AU:RHT Stock Forecast page.
More about Resonance Health Ltd
Resonance Health Ltd is an ASX-listed company operating in the medical or health-related sector, although the specific nature of its products and services is not detailed in the filing. The company’s securities trade under the ticker RHT on the Australian Securities Exchange, and it maintains a structure that supports employee equity participation through incentive schemes.
Average Trading Volume: 298,187
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$21.37M
For detailed information about RHT stock, go to TipRanks’ Stock Analysis page.